Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
Establishing immunotherapy as a standard in cancer treatment
Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA
Establishing immunotherapy as a standard in cancer treatment ( Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA )
18 Jul 2013
ECC 2013 Preview: Scientific programme highlights
Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013
Relapsed or progressive multiple myeloma
Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA
Relapsed or progressive multiple myeloma ( Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA )
20 Jun 2013
Vemurafenib and ipilimumab for metastatic melanoma
Dr Caroline Robert - Institute Gustave Roussy, Paris, France
Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )
14 Jun 2013
Importance of the immune system in cancer
Prof Leif Håkansson - Linköping University Hospital, Sweden
Importance of the immune system in cancer ( Prof Leif Håkansson - Linköping University Hospital, Sweden )
14 Jun 2013
Monoclonal antibodies and targeting them against cancer cells in lymphoma
Prof Ronald Levy - Stanford University, USA
Monoclonal antibodies and targeting them against cancer cells in lymphoma ( Prof Ronald Levy - Stanford University, USA )
14 Jun 2013
Role of microenvironment and stroma in cancer therapy
Dr Stephen Ansell - Mayo Clinic, Rochester, USA
Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )
7 Jun 2013
ASCO 2013 highlights
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
3 Jun 2013
Nivolumab blocking PD1 in lung cancer and melanoma
Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA
Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )
3 Jun 2013
Development and clinical trials of Z100
Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan
Development and clinical trials of Z100 ( Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan )
3 Jun 2013
Ipilimumab and BRAF inhibitors for advanced melanoma
Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation